Global Expansion New offices in the United Kingdom, Northern Europe, and the European Union, plus a presence in New Jersey, create regional selling opportunities. Focus on European and North American customers with local support and logistics aligned to regulatory requirements for TruCytes and related controls.

Automation Synergy A partnership with Cellares to combine TruCytes biomarkers with the Cell Q platform signals a strong automation and scale opportunity. Target biotech manufacturers and contract research organizations investing in flow cytometry and cell therapy manufacturing automation, and pursue joint solutions with bundled pricing.

Multi Site Demand Labs performing multi-site validations, potency assessments, and clinical studies require highly reproducible controls across sites. Slingshot's TruCytes and companion controls support enterprise deployments, site-wide rollouts, and volume purchases.

Leadership Growth Recent leadership appointments, including a new Chief Executive Officer and a Senior Vice President of Global Sales, signal a renewed push to scale. This creates an opportunity to engage enterprise accounts with a clear growth plan and land multi-site deals with executive sponsorship.

Comprehensive Controls The TruCytes biomarker controls, SpectraComp compensation controls, ViaComp cell health controls, and FlowCytes instrument controls form a compelling bundled offering. There are strong cross sell opportunities across flow cytometry labs, diagnostics, and drug development programs with tiered bundles.